🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Multicentric study, Phase III; this study is a randomized, participant- and...
Status
Completed
Location
Clinical Research Institute Saltillo
Start Date
2018-03-22
Trial ID
NCT03460743
The purpose of this study is to evaluate the safety and immunogenicity of a...
Status
Completed
Location
Peninsula Research Associates Site Number : 8400013
Start Date
2022-04-11
Trial ID
NCT06118151
Treatments Being Tested
The primary objectives of the study are: * To describe the safety profile ...
Status
Completed
Location
Investigational Site Number 8400003
Start Date
2020-07-02
Trial ID
NCT04451954
One dose of escalating strengths of an investigational influenza vaccine, V...
Status
Unknown
Location
Q-Pharm Pty Limited
Start Date
2014-11
Trial ID
NCT02247362
This is a multi-center, randomized, double-blind, active comparator control...
Status
Unknown
Location
Optimal Research
Start Date
2015-05
Trial ID
NCT02434276
Treatments Being Tested
Flublok was studied previously in children 6 -59 months of age and demonstr...
Status
Completed
Location
Maine Research Associates, LLC
Start Date
2013-11
Trial ID
NCT01959945
Treatments Being Tested
This is a Phase 1, single-site, comparator-controlled, dosage-escalating st...
Status
Completed
Location
University of Iowa - Infectious Disease Clinic
Start Date
2023-10-16
Trial ID
NCT05945485
The objective of this study is to evaluate the safety and immunogenicity of...
Status
Completed
Location
Paratus Clinical
Start Date
2025-03-19
Trial ID
NCT06850051
Treatments Being Tested
This is a Phase 1, parallel, randomized, active-controlled, multi-center, d...
Status
Completed
Location
Investigational Site Number : 0360004
Start Date
2023-04-12
Trial ID
NCT05829356
Treatments Being Tested